Clinical Algorithms: When to Test, Treat, Refer and Reassess Micronutrient Problems

Clinical algorithms micronutrient problems recommend testing for vitamin deficiency when specific clinical triggers or risk thresholds are present — for example serum ferritin <30 ng/mL for iron deficiency, 25‑hydroxyvitamin D <20 ng/mL for vitamin D deficiency, unexplained anemia (hemoglobin <13 g/dL in men, <12 g/dL in nonpregnant women), persistent neuropathy, malabsorption states, recent bariatric surgery, or prolonged use of high‑risk medications such as metformin or proton pump inhibitors. Testing should be targeted rather than routine, with initial assays that match the suspected deficiency (CBC with indices, ferritin, transferrin saturation, serum B12, 25‑OH vitamin D, and methylmalonic acid when B12 results are borderline). Risk‑based screening improves diagnostic yield and reduces unnecessary testing.

Mechanistically, a targeted approach relies on pretest probability, validated assays and inflammatory context; tools such as CBC, serum ferritin, transferrin saturation, 25‑hydroxyvitamin D assay, serum B12 and methylmalonic acid are common components of micronutrient testing. Standards from the World Health Organization (WHO) for anemia and Institute of Medicine (IOM) thresholds for vitamin D inform cutoffs, while diagnostic adjuncts like C‑reactive protein help interpret ferritin as an acute‑phase reactant. Using a formal nutrient deficiency assessment framework—clinical triggers, focused laboratory panels, medication and dietary risk review—reduces unnecessary panels and aligns testing with the Testing, Supplementation & Safety decision pathway. Consensus guidance supports targeted over universal screening. Point‑of‑care tools and electronic medical record order sets can implement the algorithm in primary care workflows.

A frequent misconception is equating any lab value outside the population reference range with immediate treatment; clinical context alters interpretation and action. For example, ferritin of 40 ng/mL in a patient with active inflammation or infection may not exclude iron deficiency—transferrin saturation or CRP should be assessed and iron deficiency suspected if transferrin saturation <20% or ferritin is discordant. Serum B12 of ~200–300 pg/mL can be functionally deficient if methylmalonic acid or homocysteine are elevated, a scenario common in older adults and long‑term metformin users. Clear policies on when to test vitamins minerals must specify thresholds that trigger treatment, criteria for specialist referral, and a reassess nutrient status timeline such as 8–12 weeks after starting supplementation. Mild, asymptomatic deficiencies may be managed with dietary optimization and reassess at 12 weeks.

Practically, clinicians should document clinical triggers, select focused panels, start evidence‑based supplementation (oral iron 60–200 mg elemental iron daily divided, vitamin D loading regimens per IOM or Endocrine Society guidance, B12 parenteral therapy for severe deficiency) and schedule reassessment at predictable intervals (reticulocyte response in 7–10 days for iron, hemoglobin rise by 2 g/dL by 3–4 weeks, ferritin and 25‑OH D by 8–12 weeks). Complex or refractory cases warrant referral to nutrition support or hematology. Document informed consent for high‑dose regimens and plans. This page provides a structured, step-by-step micronutrient treatment algorithm for testing, treating, referring and reassessing micronutrient problems.